www.oradesibiu.ro/2026/11/20/rezultate-spectaculoa
A study involving 61 patients with advanced pancreatic cancer showed promising results for the drug daraxonrasib, with tumors becoming undetectable in 1 out of 12 patients. The treatment halted tumor growth in 90% of participants, and over 60% experienced tumor shrinkage or disappearance. While the drug is not yet a cure, it offers hope for extended survival. Cancer Research UK hailed the findings as a significant advancement in pancreatic cancer treatment, which has one of the lowest survival rates among common cancers.
Fact-check this story: paste the text or link into Justificat.ro and get a verdict with the sources consulted.